Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD
- PMID: 24643131
- PMCID: PMC4049264
- DOI: 10.1159/000360010
Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD
Abstract
Background: Intestinal microbiome constitutes a symbiotic ecosystem that is essential for health, and changes in its composition/function cause various illnesses. Biochemical milieu shapes the structure and function of the microbiome. Recently, we found marked differences in the abundance of numerous bacterial taxa between ESRD and healthy individuals. Influx of urea and uric acid and dietary restriction of fruits and vegetables to prevent hyperkalemia alter ESRD patients' intestinal milieu. We hypothesized that relative abundances of bacteria possessing urease, uricase, and p-cresol- and indole-producing enzymes is increased, while abundance of bacteria containing enzymes converting dietary fiber to short-chain fatty acids (SCFA) is reduced in ESRD.
Methods: Reference sets of bacteria containing genes of interest were compiled to family, and sets of intestinal bacterial families showing differential abundances between 12 healthy and 24 ESRD individuals enrolled in our original study were compiled. Overlap between sets was assessed using hypergeometric distribution tests.
Results: Among 19 microbial families that were dominant in ESRD patients, 12 possessed urease, 5 possessed uricase, and 4 possessed indole and p-cresol-forming enzymes. Among 4 microbial families that were diminished in ESRD patients, 2 possessed butyrate-forming enzymes. Probabilities of these overlapping distributions were <0.05.
Conclusions: ESRD patients exhibited significant expansion of bacterial families possessing urease, uricase, and indole and p-cresol forming enzymes, and contraction of families possessing butyrate-forming enzymes. Given the deleterious effects of indoxyl sulfate, p-cresol sulfate, and urea-derived ammonia, and beneficial actions of SCFA, these changes in intestinal microbial metabolism contribute to uremic toxicity and inflammation.
Similar articles
-
The Accumulation of Gut Microbiome-derived Indoxyl Sulfate and P-Cresyl Sulfate in Patients With End-stage Renal Disease.J Ren Nutr. 2022 Sep;32(5):578-586. doi: 10.1053/j.jrn.2021.09.007. Epub 2021 Nov 2. J Ren Nutr. 2022. PMID: 34736844
-
Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study.Microbiome. 2016 Sep 17;4(1):50. doi: 10.1186/s40168-016-0195-9. Microbiome. 2016. PMID: 27640125 Free PMC article.
-
Preliminary evaluation of fecal fatty acid concentrations in cats with chronic kidney disease and correlation with indoxyl sulfate and p-cresol sulfate.J Vet Intern Med. 2020 Jan;34(1):206-215. doi: 10.1111/jvim.15634. Epub 2019 Nov 6. J Vet Intern Med. 2020. PMID: 31693251 Free PMC article.
-
Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney disease.Expert Rev Clin Pharmacol. 2018 Jan;11(1):71-82. doi: 10.1080/17512433.2018.1378095. Epub 2017 Sep 20. Expert Rev Clin Pharmacol. 2018. PMID: 28905671 Free PMC article. Review.
-
Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.Curr Diab Rep. 2017 Mar;17(3):16. doi: 10.1007/s11892-017-0841-z. Curr Diab Rep. 2017. PMID: 28271466 Review.
Cited by
-
Supplementation with soluble or insoluble rice-bran fibers increases short-chain fatty acid producing bacteria in the gut microbiota in vitro.Front Nutr. 2024 May 10;11:1304045. doi: 10.3389/fnut.2024.1304045. eCollection 2024. Front Nutr. 2024. PMID: 38798771 Free PMC article.
-
An altered gut microbiome in pre-eclampsia: cause or consequence.Front Cell Infect Microbiol. 2024 May 7;14:1352267. doi: 10.3389/fcimb.2024.1352267. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38774629 Free PMC article. Review.
-
Ferroptosis: a potential bridge linking gut microbiota and chronic kidney disease.Cell Death Discov. 2024 May 15;10(1):234. doi: 10.1038/s41420-024-02000-8. Cell Death Discov. 2024. PMID: 38750055 Free PMC article. Review.
-
Yi-Shen-Hua-Shi regulates intestinal microbiota dysbiosis and protects against proteinuria in patients with chronic kidney disease: a randomized controlled study.Pharm Biol. 2024 Dec;62(1):356-366. doi: 10.1080/13880209.2024.2345080. Epub 2024 May 9. Pharm Biol. 2024. PMID: 38720666 Free PMC article. Clinical Trial.
-
Lactobacillus acidophilus KBL409 protects against kidney injury via improving mitochondrial function with chronic kidney disease.Eur J Nutr. 2024 May 6. doi: 10.1007/s00394-024-03408-9. Online ahead of print. Eur J Nutr. 2024. PMID: 38705901
References
-
- Vaziri ND, Wong J, Pahl MV, et al. Chronic kidney disease alters the composition of intestinal microbial flora. Kidney Int. 2013;83:308–315. - PubMed
-
- Lee YT. Urea concentration in intestinal fluids in normal and uremic dogs. J Surg Oncol. 1971;3:163–168. - PubMed
-
- Swales JD, Tange JD, Evans DJ. Intestinal ammonia in uraemia: the effect of a urease inhibitor, acetohydroxamic acid. Clin Sci. 1972;42:105–112. - PubMed
-
- Kang JY. The gastrointestinal tract in uremia. Dig Dis Sci. 1993;38:257–268. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical